LSV Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271M | Buy |
|
|||||
|
2025
Q1 | $306M | Sell |
|
|||||
|
2024
Q4 | $312M | Buy |
|
|||||
|
2024
Q3 | $278M | Buy |
|
|||||
|
2024
Q2 | $265M | Buy |
|
|||||
|
2024
Q1 | $287M | Buy |
|
|||||
|
2023
Q4 | $288M | Sell |
|
|||||
|
2023
Q3 | $307M | Buy |
|
|||||
|
2023
Q2 | $287M | Sell |
|
|||||
|
2023
Q1 | $339M | Buy |
|
|||||
|
2022
Q4 | $328M | Buy |
|
|||||
|
2022
Q3 | $235M | Buy |
|
|||||
|
2022
Q2 | $270M | Sell |
|
|||||
|
2022
Q1 | $281M | Sell |
|
|||||
|
2021
Q4 | $234M | Sell |
|
|||||
|
2021
Q3 | $245M | Sell |
|
|||||
|
2021
Q2 | $351M | Sell |
|
|||||
|
2021
Q1 | $341M | Sell |
|
|||||
|
2020
Q4 | $375M | Sell |
|
|||||
|
2020
Q3 | $348M | Buy |
|
|||||
|
2020
Q2 | $246M | Buy |
|
|||||
|
2020
Q1 | $186M | Sell |
|
|||||
|
2019
Q4 | $279M | Buy |
|
|||||
|
2019
Q3 | $221M | Buy |
|
|||||
|
2019
Q2 | $161M | Buy |
|
|||||
|
2019
Q1 | $143M | Buy |
|
|||||
|
2018
Q4 | $94.8M | Buy |
|
|||||
|
2018
Q3 | $50.2M | Buy |
|
|||||
|
2018
Q2 | $49.7M | Buy |
|
|||||
|
2018
Q1 | $34.8M | Buy |
|
|||||
|
2017
Q4 | $21.5M | Buy |
|
|||||
|
2017
Q3 | $19.4M | Buy |
|
|||||
|
2017
Q2 | $13.6M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $252K | Buy |
|